Original Research

Published on 16 Jun 2020

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Ken Kuwahara
Tatsuya Sasaki
Takao Yasuhara
Masahiro Kameda
Yosuke Okazaki
Kakeru Hosomoto
Ittetsu Kin
Mihoko Okazaki
Satoru Yabuno
Satoshi Kawauchi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00164

4,710 views
21 citations

Original Research

Published on 05 Jun 2020

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Yanxuan Li
Zili Zhu
Jie Chen
Minming Zhang
Yunjun Yang
Peiyu Huang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00161

4,895 views
27 citations

Review

Published on 05 Jun 2020

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation

in Parkinson’s Disease and Aging-related Movement Disorders

Sara Belloli
Michele Morari
Valentina Murtaj
Silvia Valtorta
Rosa Maria Moresco
Maria Carla Gilardi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00152

9,025 views
34 citations

Original Research

Published on 26 May 2020

Brain Functional and Structural Signatures in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Chunhua Liu
Jiehui Jiang
Hucheng Zhou
Huiwei Zhang
Min Wang
Juanjuan Jiang
Ping Wu
Jingjie Ge
Jian Wang
Yilong Ma

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00125

5,318 views
5 citations

Original Research

Published on 22 May 2020

Natural Reading in Parkinson’s Disease With and Without Mild Cognitive Impairment

in Parkinson’s Disease and Aging-related Movement Disorders

Lena Stock
Charlotte Krüger-Zechlin
Zain Deeb
Lars Timmermann
Josefine Waldthaler

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00120

5,723 views
12 citations

Brief Research Report

Published on 14 May 2020

Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage

in Parkinson’s Disease and Aging-related Movement Disorders

Ewa Papuć
Konrad Rejdak

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00128

2,959 views
9 citations

General Commentary

Published on 13 May 2020

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model

in Parkinson’s Disease and Aging-related Movement Disorders

Kuti Baruch
Eti Yoles

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00135

3,005 views
2 citations

Original Research

Published on 28 Apr 2020

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Nai-Ching Chen
Hsiu-Ling Chen
Shau-Hsuan Li
Yen-Hsiang Chang
Meng-Hsiang Chen
Nai-Wen Tsai
Chiun-Chieh Yu
Shieh-Yueh Yang
Cheng-Hsien Lu
Wei-Che Lin

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00112

6,650 views
36 citations

Review

Published on 21 Apr 2020

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Micol Avenali
Fabio Blandini
Silvia Cerri

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00097

18,344 views
70 citations

Review

Published on 21 Apr 2020

Mitochondrial Homeostasis and Signaling in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Antonella Scorziello
Domenica Borzacchiello
Maria Jose Sisalli
Rossana Di Martino
Micaela Morelli
Antonio Feliciello

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00100

8,775 views
35 citations

Review

Published on 03 Apr 2020

Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy

in Parkinson’s Disease and Aging-related Movement Disorders

Aaron Song Chuan Foo
Tuck Wah Soong
Tseng Tsai Yeo
Kah-Leong Lim

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00089

22,658 views
37 citations

Original Research

Published on 31 Mar 2020

Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Shaoqi Yan
Xinbing Wei
Wencheng Jian
Yue Qin
Jia Liu
Shaowei Zhu
Fan Jiang
Haiyan Lou
Bin Zhang

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00078

7,712 views
44 citations

Original Research

Published on 27 Mar 2020

Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37

in Parkinson’s Disease and Aging-related Movement Disorders

Xiaoqun Zhang
Ioannis Mantas
Elva Fridjonsdottir
Per E. Andrén
Karima Chergui
Per Svenningsson

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00084

5,304 views
17 citations

Review

Published on 24 Mar 2020

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Arianna Bellucci
Luigi Bubacco
Francesca Longhena
Edoardo Parrella
Gaia Faustini
Vanessa Porrini
Federica Bono
Cristina Missale
Marina Pizzi

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00068

8,926 views
69 citations

Mini Review

Published on 17 Mar 2020

Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease

in Parkinson’s Disease and Aging-related Movement Disorders

Sarah M. Hernandez
Elena B. Tikhonova
Andrey L. Karamyshev

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00072

11,555 views
29 citations

Original Research

Published on 17 Mar 2020

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia

in Parkinson’s Disease and Aging-related Movement Disorders

Changwei Yang
Tingting Zhang
Wuqiong Wang
Yilan Xiang
Qun Huang
Chenglong Xie
Liangcai Zhao
Hong Zheng
Yunjun Yang
Hongchang Gao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2020.00075

5,849 views
19 citations

Navigation group

Articles

Long-Term Continuous Cervical Spinal Cord Stimulation Exerts Neuroprotective Effects in Experimental Parkinson’s Disease

Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson’s Disease

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation

Brain Functional and Structural Signatures in Parkinson’s Disease

Natural Reading in Parkinson’s Disease With and Without Mild Cognitive Impairment

Increased CSF NFL in Non-demented Parkinson’s Disease Subjects Reflects Early White Matter Damage

Commentary: Chronic PD-1 Checkpoint Blockade Does Not Affect Cognition or Promote Tau Clearance in a Tauopathy Mouse Model

Plasma Levels of α-Synuclein, Aβ-40 and T-tau as Biomarkers to Predict Cognitive Impairment in Parkinson’s Disease

Glucocerebrosidase Defects as a Major Risk Factor for Parkinson’s Disease

Mitochondrial Homeostasis and Signaling in Parkinson’s Disease

Mitochondrial Dysfunction and Parkinson’s Disease—Near-Infrared Photobiomodulation as a Potential Therapeutic Strategy

Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson’s Disease

Deficits in Motor Performance, Neurotransmitters and Synaptic Plasticity in Elderly and Experimental Parkinsonian Mice Lacking GPR37

Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease

Protein-Protein Interactions in Alpha-Synuclein Biogenesis: New Potential Targets in Parkinson’s Disease

Brain-Region Specific Metabolic Abnormalities in Parkinson’s Disease and Levodopa-Induced Dyskinesia